Rigel Pharmaceuticals in-licensed Veppanu, a drug for the treatment of certain breast cancer patients, targeting a $1B market ...

Chinese drugmakers are seeing a deeper and wider presence overseas, with homegrown innovative pharmaceuticals underpinned by a maturing innovation ecosystem and a favorable policy environment, ...

According to the company, the system remained operational through the test, carried out its designated processes in a harsh ...

New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of ...

The INSULIN Act would cap insulin costs for privately insured patients as Congress considers broader measures targeting drug ...

"This policy could cause generic drug shortages or aggravate existing shortages," policy expert Rena Conti told Newsweek.

Essential cancer medications are getting more difficult for hospitals to source, experts say.

Defective drugs are, unfortunately, a very real concern for patients across the United States. While pharmaceutical companies have an obligation ...

Jazz Pharmaceuticals stock buys Actio Biosciences for $820 million to boost the KCNT1 epilepsy pipeline as Q2 2026 hits $1.2 ...

Pharmaceutical and biotech companies are rushing to develop new generations of antibody-drug conjugates (ADCs) for treating ...

This problem has a solution, and Pfizer is implementing it.